Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
- Resource Type
- Article
- Authors
- Davids, Matthew S ; Lampson, Benjamin L; Tyekucheva, Svitlana; Wang, Zixu; Lowney, Jessica C; Pazienza, Samantha; Montegaard, Josie; Patterson, Victoria; Weinstock, Matthew; Crombie, Jennifer L; Ng, Samuel Y; Kim, Austin I; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Arnason, Jon E; Fisher, David C; Brown, Jennifer R
- Source
- In The Lancet Oncology October 2021 22(10):1391-1402
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045